Article info
PDFClinical science
Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre
- Correspondence to Dr Carol L Shields, Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA; carolshields{at}gmail.com
Citation
Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre
Publication history
- Received November 19, 2019
- Revised January 18, 2020
- Accepted January 24, 2020
- First published February 12, 2020.
Online issue publication
October 26, 2020
Article Versions
- Previous version (12 February 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.